Early diagnosis and treatment of SMA can limit disease progression in children and adults, extending life expectancy and improving QOL. Spinal muscular atrophy (SMA) is a severe genetic condition that ...

Spinal muscular atrophy with respiratory distress (SMARD) is a rare genetic condition that typically affects infants and children. It causes muscle weakness and breathing problems. Spinal muscular ...

Spinal muscular atrophy and muscular dystrophy both affect muscle size and function, causing weakness and leading to health complications like difficulty walking, swallowing, and, for some people, ...

Spinal muscular atrophy (SMA) type 0 is a rare genetic disorder that affects the ability to control muscle movement. It’s present before birth, and infants born with the condition will need immediate ...

Risdiplam, an oral pre–messenger RNA splicing modifier, is an efficacious treatment for persons with symptomatic spinal muscular atrophy (SMA). The safety and efficacy of risdiplam in presymptomatic ...

Panelists discuss how spinal muscular atrophy is an autosomal recessive genetic disease affecting motor neurons with 3 currently approved disease-modifying therapies that restore SMN protein ...

Spinal muscular atrophy (SMA) can cause weakness, difficulty controlling movements, and difficulty swallowing and breathing. It can be carried in certain genes. Spinal muscular atrophy (SMA) is a ...

A recent Harvard study introduces a new method for treating spinal muscular atrophy. The study used "base editing" to target the disease's root cause by modifying the survival motor neuron gene. For ...

Spinal muscular atrophy (SMA) is a genetic condition that is passed down through families. It leads to muscle weakness, which may affect everyday functions such as head movement, sitting without help, ...

Mitochondria are essential cellular components that act as powerhouses. The fusion of two or more mitochondria, and the fission of a mitochondrion into two units are common phenomena known as ...